vTv Therapeutics Inc. Class A Common Stock (VTVT) News

Latest headlines that mention VTVT, newest first · each headline opens the original publisher

VTVT quote

Last price: $25.81
Day change: +1.02%
Next earnings: 2026-11-05

Quote & chart Expected move Insider trading IV rank history

VTVT headlines

latest coverage

Not much coverage yet. VTVT has appeared in only a few headlines lately; new stories show up here as publishers cover it.

Seeking Alpha News 5d ago

vTv Therapeutics Inc. (VTVT) Discusses Hypoglycemia Burden in Type 1 Diabetes and Cadisegliatin Phase 3 Program - Slideshow

General T2VTVT

Seeking Alpha News 6d ago

vTv Therapeutics Inc. (VTVT) Discusses Hypoglycemia Burden in Type 1 Diabetes and Cadisegliatin Phase 3 Program Transcript

General T2VTVT

Seeking Alpha 19d ago

vTv Therapeutics' sickle cell asset HPPD gains FDA orphan drug status

General T2VTVT

Investing.com 21d ago

vTv Therapeutics completes Phase 3 enrollment for T1D drug

General T3VTVT

Seeking Alpha 5mo ago

vTv Therapeutics GAAP EPS of $1.65 beats by $1.21, revenue of $36.84M beats by $26.84M

Earnings T2VTVT

VTVT news alerts

Get an alert by email or push when a new headline mentions VTVT.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.